A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : sTNF-RI / soluble tumor necrosis factor receptor I

[Related PubMed/MEDLINE]
Total Number of Papers: 76
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   sTNF-RI  (>> Co-occurring Abbreviation)
Long Form:   soluble tumor necrosis factor receptor I
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
1  2020 Insulin resistance and intestinal integrity in children with and without HIV infection in Uganda. ART, BMI, HDL, HEUs, HOMA-IR, HUUs, IQR
2  2019 Comparison of serum biomarkers for the diagnosis of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis. MAS, sJIA
3  2019 Cytokine profile of macrophage activation syndrome associated with Kawasaki disease. IFN, IL, KD, MAS
4  2019 Plasma biomarkers of inflammation, coagulation, and brain injury as predictors of delirium duration in older hospitalized patients. BBB, ED, IL-6, PAI-1
5  2018 Variability in C-reactive protein is associated with cognitive impairment in women living with and without HIV: a longitudinal study. CI, CRP, IL, MMP
6  2017 Immune activation, smoking, and vaccine response. ---
7  2017 Incidental findings on chest computed tomography are common and linked to inflammation in HIV-infected adults. ART, CT, ILF, Lp-PLA2
8  2016 A highly efficient bead extraction technique with low bead number for digital microfluidic immunoassay. DMF
9  2016 A novel murine model of Clostridium sordellii myonecrosis: Insights into the pathogenesis of disease. G-CSF, IL-6
10  2016 Differential Protein Expression Profiles in Glaucomatous Trabecular Meshwork: An Evaluation Study on a Small Primary Open Angle Glaucoma Population. ICAM3, IL, MIP, MMP7, POAG, TGF-beta1, TIMP1, TM, VEGF
11  2016 Systemic inflammation and liver damage in HIV/hepatitis C virus coinfection. APRI, ART, AST, HCV, I-FABP, IL, IP, LPS, RTEs, sCD163
12  2016 The assessment of the prognostic value of tumor markers and cytokines as SCCAg, CYFRA 21.1, IL-6, VEGF and sTNF receptors in patients with squamous cell cervical cancer, particularly with early stage of the disease. DFS, FIGO, IL-6, OS, SCC-Ag, VEGF
13  2015 Differential Reduction in Monocyte Activation and Vascular Inflammation With Integrase Inhibitor-Based Initial Antiretroviral Therapy Among HIV-Infected Individuals. ART, HIV, hs-CRP, IL-6, Lp-PLA2, sCD14, sCD163
14  2015 [Reproduction of a model of "two-hit" sepsis model with complication of pneumonia in rat]. ALT, AST, BUN, CLP, DC, HMGB1, SCr, SD, TGF-beta1, TNF-alpha, Treg
15  2014 Soluble markers of inflammation and coagulation but not T-cell activation predict non-AIDS-defining morbid events during suppressive antiretroviral treatment. ART, HIV, IL-6, KT
16  2013 Inflammation in complex regional pain syndrome: a systematic review and meta-analysis. CRPS, IL, MCP-1, sICAM-1
17  2013 Pentoxifylline, inflammation, and endothelial function in HIV-infected persons: a randomized, placebo-controlled trial. FMD, NTGMD, PTX
18  2012 Proteomic biomarker discovery in cerebrospinal fluid for cerebral vasospasm following subarachnoid hemorrhage. ADMA, APOE, CSF, F2-IsoP, ICAM-1, IL, MCP-1, mTF, PDGF, SAH, SBDPs, TAT, TNF, VCAM-1
19  2011 Determination of soluble tumor necrosis factor-alpha receptor type I (TNFRI) and II (TNFRII) in the urine of healthy Japanese subjects. HUS, TNFRI
20  2011 Evidence of a significant role for Fas-mediated apoptosis in HCV clearance during pegylated interferon plus ribavirin combination therapy. NR, sFas, sFasL, SVR
21  2011 Physical activity level in Achilles tendinosis is associated with blood levels of pain-related factors: a pilot study. BDNF, TNF-alpha
22  2011 [Evaluation of bone mineral density, bone turnover markers, the OPG/RANKL system and sTNF-RI in Crohn's disease]. BALP, BMD, CTX, OC, OPG, RANKL, TRAP
23  2010 Clinical significance of serum CA-125 and soluble tumor necrosis factor receptor type I in cervical adenocarcinoma patients. CEA, IL-6, SCC
24  2010 Serum soluble tumour necrosis factor receptor type I concentrations independently predict prognosis in patients with breast cancer. bFGF, IL-10, IL-1ra, IL-6, IL-8, TNF-alpha, VEGF
25  2010 The relationship between serum level of N-terminal pro-B-type natriuretic peptide and nutritional status, and inflammation in chronic hemodialysis patients. ALB, BIA, BMI, CG, Hb, HD, IBWG, IL-6, MAP, NT-pro-BNP
26  2009 Light-induced aggregation of type I soluble tumor necrosis factor receptor. ---
27  2009 Nutrition, anthropometry, gastrointestinal dysfunction, and circulating levels of tumour necrosis factor alpha receptor I and interleukin-1 receptor antagonist in children during stem cell transplantation. IL-1ra, SCT
28  2009 Soluble tumor necrosis factor receptor-I in preterm infants with chorioamnionitis. CAM
29  2009 Spermine protects mice against lethal sepsis partly by attenuating surrogate inflammatory markers. DAMPs, HMGB1, i.p, IL-6, KC, MCP-1, MIP-2, PAMPs, sTNF-RII, TIMP-1
30  2009 [The comparative proteomic analysis of serum cytokine expression in acute lung injury patients in peri-operative stage of liver transplantation]. ALI, M-CSF, MCP-2, MIG, MIP-1alpha, PDGF-BB
31  2008 Human soluble tumor necrosis factor receptor I (sTNF-RI) and interleukin-I receptor antagonist (IL-I Ra) in different stages of acute rheumatic fever. ARF, ELISA, IL-IRa
32  2008 Predictors of fatigue in obstructive sleep apnea. BMI, IL-6, OSA
33  2007 Correlation between sTNFR-I and other negative prognostic factors in patients with chronic heart failure. LVEF
34  2007 Ibuprofen does not affect levels of tumor necrosis factor alpha and soluble tumor necrosis factor receptor types I and II in Gabonese children with uncomplicated Plasmodium falciparum malaria. sTNF-RII, TNF-alpha
35  2007 Preoperative plasma levels of soluble tumor necrosis factor receptor type I (sTNF-RI) predicts adverse events in cardiac surgery. ---
36  2007 [Cytokines and other immunological parameters as markers of distant organ involvement in acute pancreatitis]. AP, ICAM-1, IL, sIL-6R
37  2006 Dietary apigenin suppresses IgE and inflammatory cytokines production in C57BL/6N mice. Ig, RANTES
38  2006 Differential effect of conditioning regimens on cytokine responses during allogeneic stem cell transplantation. ATG, IL, IL-Ra, SCT
39  2006 Suppression of experimental osteoarthritis by adenovirus-mediated double gene transfer. IL-1, IL-1ra, OA, PFU, TNF-alpha
40  2006 The role of soluble tumor necrosis factor receptor types I and II and tumor necrosis factor-alpha in malaria during pregnancy. sTNF-RII, TNF-alpha
41  2005 Cytokines and soluble tumour necrosis factor I receptor levels during pretransplant conditioning in allogeneic stem-cell transplantation. SCT
42  2004 Association between serum levels of soluble tumor necrosis factor receptors/CA 125 and disease progression in patients with epithelial ovarian malignancy: a gynecologic oncology group study. CI, HR
43  2004 Type 2 diabetes in patients with end-stage renal disease is not associated with further increased serum inflammatory parameters. CRP, ESRD, HD, IL-6
44  2003 Design of PEGylated soluble tumor necrosis factor receptor type I (PEG sTNF-RI) for chronic inflammatory diseases. ACR
45  2003 [Management of postoperative inflammatory response and pain with nimesulide after cardiac surgery]. COX-2, CRP, IL-6, NSAID, WBC
46  2002 Association of increased hepatitis C virus (HCV)-specific IgG and soluble CD26 dipeptidyl peptidase IV enzyme activity with hepatotoxicity after highly active antiretroviral therapy in human immunodeficiency virus-HCV-coinfected patients. DPP-IV, HAART, HCV, HIV, IgG
47  2002 Effects of extracorporeal photoimmunotherapy on soluble IL-2Ralpha, TNF-RI, and CD8 in patients with steroid-resistant acute graft-versus-host disease. ECP, GVHD, sCD8, sIL-2Ralpha
48  2002 Interactions between PEG and type I soluble tumor necrosis factor receptor: modulation by pH and by PEGylation at the N terminus. PEG
49  2002 Multiplexed protein profiling on microarrays by rolling-circle amplification. DCs, IL, IP, LPS, MDC, MIP, RCA, sIL-6R, TARC, TNF-alpha
50  2002 Serum tryptophan decrease correlates with immune activation and impaired quality of life in colorectal cancer. IL-2 sRalpha
51  2002 The soluble tumor necrosis factor receptor I is an early predictor of local infective complications after colorectal surgery. ---
52  2001 Blunted erythropoietic response to anemia in multiply traumatized patients. EPO, IL-1ra, IL-6, TNF-alpha
53  2001 Cytokine profile of serum and bronchoalveolar lavage fluids following thoracic esophageal cancer surgery. BALFs, IL, IL-1ra, LRT
54  2001 Lack of induction of interleukin-2-receptor-alpha in patients with tuberculosis and human immunodeficiency virus co-infection: implications for pathogenesis. HIV, IL-2, IL-2R alpha, sIL-2R-alpha, TB
55  2001 [Changes of serum soluble tumor necrosis factor receptor I in patients with rheumatic fever]. CRHD
56  2001 [Expression and significance of serum soluble tumor necrosis factor receptor-I in patients with head and neck neoplasm]. ---
57  2000 Plasma concentrations of soluble tumor necrosis factor receptor I and tumor necrosis factor during cardiopulmonary bypass. TNF
58  2000 Prostaglandin E1 reduces myocardial reperfusion injury by inhibiting proinflammatory cytokines production during cardiac surgery. CK-MB, IL, IL-1ra, PGE1, sTNF-RII
59  2000 Randomized controlled trial of the effect of early enteral nutrition on markers of the inflammatory response in predicted severe acute pancreatitis. CRP, IL
60  2000 Soluble tumor necrosis factor receptor I (sTNFRI) as a prognostic factor in melanoma patients in Slovene population. mAbs, TNF-alpha
61  2000 Soluble tumor necrosis factor receptor I (sTNFRI) as a prognostic factor in melanoma patients in Slovene population. mAbs, TNF-alpha
62  2000 Soluble tumor necrosis factor receptor type I enhances tumor development and persistence in vivo. ---
63  2000 Topical soluble tumor necrosis factor receptor type I suppresses ocular chemokine gene expression and rejection of allogeneic corneal transplants. ---
64  2000 Tuberculosis (TB) and HIV infection are independently associated with elevated serum concentrations of tumour necrosis factor receptor type 1 and beta2-microglobulin, respectively. TB
65  2000 Variations in plasma soluble tumour necrosis factor receptors after diet-induced weight loss in obesity. ---
66  1999 Soluble tumor necrosis factor alpha receptors in sera from leprosy patients. ---
67  1999 The cytokines IL-1beta and IL-1 receptor antagonist, IL-2 and IL-2 soluble receptor-alpha, IL-6 and IL-6 soluble receptor, TNF-alpha and TNF soluble receptor I, and IL10 in drained and systemic blood after major orthopaedic surgery. Hb, IL-10, IL-1beta, IL-1ra, IL-2, IL-2 sRalpha, IL-6, IL-6sR, TNF-alpha, WCC
68  1999 [TNF-alpha and soluble TNF receptor p55 in patients wtih multiple sclerosis]. CSF, MS, TNF-alpha
69  1998 Increased serum concentrations of soluble tumor necrosis factor receptor I in noncachectic and cachectic patients with advanced gastric and colorectal cancer. IAP
70  1998 Inflammatory reactions in placental blood of Plasmodium falciparum-infected women and high concentrations of soluble E-selectin and a circulating P. falciparum protein in the cord sera. GLURP, IL-10, sICAM-1, sVCAM-1
71  1998 Multifaceted inhibition of anti-tumour immune mechanisms by soluble tumour necrosis factor receptor type I. ---
72  1997 Release of soluble tumor necrosis factor receptors from polymorphonuclear cells of breast cancer patients. PMNs, sTNF-RII, sTNFRs
73  1997 The potential of serum levels of soluble tumour necrosis factor receptor I as a biochemical marker in cervical cancer. ---
74  1997 [Serum levels of tumor necrosis factor alpha and soluble tumor necrosis factor-receptor I in asthmatic patients and patients with chronic respiratory tract infection]. ECP, TNF-alpha
75  1995 Production of soluble tumor necrosis factor receptor type I in Escherichia coli: optimization of the refolding yields by a microtiter dilution assay. ELISA
76  1993 Evidence of participation of the soluble tumor necrosis factor receptor I in the host response to intrauterine infection in preterm labor. ELISA